Results 141 to 150 of about 2,864 (172)

Bedaquiline, Delamanid, Linezolid, and Clofazimine for Treatment of Pre-extensively Drug-Resistant Tuberculosis

Clinical Infectious Diseases, 2023
Anuj Bhatnagar, Rajesh Solanki, Rohit Sarin   +2 more
exaly  

Delamanid

Drugs of the Future, 2013
openaire   +1 more source

Population Pharmacokinetic Analysis of Delamanid in Patients with Pulmonary Multidrug-Resistant Tuberculosis

Antimicrobial Agents and Chemotherapy, 2020
Suresh Mallikaarjun
exaly  

Delamanid

Reactions Weekly, 2016
openaire   +1 more source

Delamanid/linezolid

Reactions Weekly, 2020
openaire   +1 more source

Delamanid/linezolid

Reactions Weekly, 2019
openaire   +1 more source

Emergence of Low-level Delamanid and Bedaquiline Resistance During Extremely Drug-resistant Tuberculosis Treatment

Clinical Infectious Diseases, 2019
Matthias Merker, David Krieger, Stefan Niemann   +2 more
exaly  

Bedaquiline/delamanid

Reactions Weekly, 2020
openaire   +1 more source

Delamanid (antituberculoso nuevo) síntesis

2022
Torres, Hector, La Parra, Mario González-De   +1 more
openaire   +1 more source

In Vitro Activity of Bedaquiline and Delamanid against Nontuberculous Mycobacteria, Including Macrolide-Resistant Clinical Isolates

Antimicrobial Agents and Chemotherapy, 2019
Byung Woo Jhun, Seong Mi Moon, Su－Young Kim   +2 more
exaly